34
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Pantoprazole is Superior to Ranitidine in the Treatment of Acute Gastric Ulcer

, , &
Pages 111-115 | Received 17 Feb 1994, Accepted 30 May 1994, Published online: 08 Jul 2009
 

Abstract

Background: Pantoprazole is a newly developed gastric H+/K+-adenosine triphosphatase inhibitor with a potent and long-acting inhibitory effect on gastric acid secretion. Methods: In a double-blind multicenter study with 28 centers in Germany, pantoprazole (40 mg before breakfast) was compared with ranitidine (300 mg at bedtime) with regard to healing rates, time until healing, symptom relief, and tolerability. A total of 248 outpatients with benign gastric ulcer were included. Results: The healing rates after 2, 4, and 8 weeks were 37%, 87%, and 97%, respectively, in the pantoprazole and 19%, 58%, and 80% in the ranitidine group. The differences between the two groups were significant at 2 weeks (p < 0.01), 4 weeks (p < 0.001), and 8 weeks (p < 0.001; Cochran/Mantel-Haenszel method). Ulcer healing proceeded significantly faster with pantoprazole (p < 0.001; Uleman's U-test). Both treatments were well tolerated. Conclusions: Pantoprazole appears to be superior to ranitidine in gastric ulcer healing.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.